alecensa
roche registration gmbh - alectinibhydrochlorid - carcinom, ikke-småcellet lunge - antineoplastiske midler - alecensa som monoterapi er indiceret til førstegangsbehandling af voksne patienter med anaplastisk lymfomkinase (alk) -positive avanceret ikke-småcellet lungecancer (nsclc). alecensa som monoterapi er indiceret til behandling af voksne patienter med alk‑positive avanceret nsclc, der tidligere er behandlet med crizotinib.
lorviqua
pfizer europe ma eeig - lorlatinib - carcinom, ikke-småcellet lunge - antineoplastic agents, protein kinase inhibitors - lorviqua as monotherapy is indicated for the treatment of adult patients with anaplastic lymphoma kinase (alk)‑positive advanced non‑small cell lung cancer (nsclc) previously not treated with an alk inhibitor. lorviqua as monotherapy is indicated for the treatment of adult patients with alk‑positive advanced nsclc whose disease has progressed after:alectinib or ceritinib as the first alk tyrosine kinase inhibitor (tki) therapy; orcrizotinib and at least one other alk tki.
lumeblue (previously known as methylthioninium chloride cosmo)
alfasigma s.p.a. - methylthioniniumchlorid - colorectal neoplasms; colonoscopy - other diagnostic agents - lumeblue is indicated as a diagnostic agent enhancing visualisation of colorectal lesions in adult patients undergoing screening or surveillance colonoscopy.
flecainid "sandoz" 100 mg tabletter
sandoz a/s - flecainidacetat - tabletter - 100 mg
flecainid "stada" 100 mg tabletter
stada arzneimittel ag - flecainidacetat - tabletter - 100 mg
flecainid "2care4" 50 mg tabletter
2care4 aps - flecainidacetat - tabletter - 50 mg
flecainid "2care4" 50 mg tabletter
2care4 aps - flecainidacetat - tabletter - 50 mg
flecainid "actavis" 100 mg tabletter
actavis group ptc ehf. - flecainidacetat - tabletter - 100 mg
flecainid "paranova" 100 mg tabletter
paranova danmark a/s - flecainidacetat - tabletter - 100 mg
axitinib "stada" 1 mg filmovertrukne tabletter
stada arzneimittel ag - axitinib - filmovertrukne tabletter - 1 mg